In the special “GENETIC INSTABILITY” of Swiss Oncology in Motion, Prof. Dr. med. Viola Heinzelmann-Schwarz (University Hospital Basel), Prof. Dr. med. Jens Huober (Canton Hospital St. Gallen), PD Dr. med. Aurelius Omlin (OnkoZentrum Zürich), Prof. Dr. med. Dr. phil. Andreas Wicki (University Hospital Zurich) and Prof. Dr. med. Wolfram Jochum (Cantonal Hospital St. Gallen) discussed the role of genetic instability in various tumor types, in particular ovarian and endometrial carcinomas, breast carcionoma, GI tumors, and prostate, urothelial, and renal cell carcinomas, and how it influences treatment options. The discussion will be led by Prof. em. Richard Herrmann, MD, Basel, moderated.
You May Also Like
- Diabetes mellitus
Treatment of comorbidities in older people
- Alternative to insulin and GLP1
From the β-cell to the center: the versatile role of amylin
- Pulmonary sarcoidosis
Prednisone vs. MTX: a draw after 24 weeks
- Friedreich's ataxia
Loss of orientation in the cerebellum
- Diabetes mellitus
Treatment of comorbidities in older people
- Artificial intelligence
Dr. ChatGPT: Large language models in everyday clinical practice
- Subtyping as the key to precision medicine
Molecular diversity of the PDAC
- Multiple sclerosis